DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR THE DETERMINATION OF RESVERATROL IN BULK DOSAGE FORM, COMMERCIAL TABLET, AND MULTIWALLED CARBON NANOTUBES-BASED FORMULATION

NEHA SHARMA; YACHANA MISHRA; NEELAM SHARMA; VIJAY MISHRA

doi:10.22159/ijap.2025v17i6.54953

Authors

NEHA SHARMA School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab)-144411, India. ASBASJSM College of Pharmacy Bela, Ropar-104111, India https://orcid.org/0009-0007-3264-4387
YACHANA MISHRA School of Bioengineering and Biosciences, Lovely Professional University, Phagwara (Punjab)-144411, India https://orcid.org/0000-0002-3467-0518
NEELAM SHARMA ASBASJSM College of Pharmacy Bela, Ropar-104111, India https://orcid.org/0000-0003-1198-7085
VIJAY MISHRA School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab)-144411, India https://orcid.org/0000-0001-6542-2464

DOI:

https://doi.org/10.22159/ijap.2025v17i6.54953

Keywords:

Resveratrol, Multiwalled carbon nanotubes, HPLC, Validation

Abstract

Objective: Resveratrol (RES), a polyphenol, is a promising option to treat multiple diseases due to its anticancer, cardioprotective, anti-inflammatory, and antioxidant activities. The present study was designed to develop and validate a simple, precise, rapid and reproducible analytical method for the detection of RES in different formulations.

Methods: A novel analytical technique was developed and validated for the detection of RES via ultrafast liquid chromatography utilizing C₁₈ column. Methanol along with high-performance liquid chromatography (HPLC) grade water (40:60) was used as a mobile phase with a rate of flow of 0.8 ml/min. This technique has been validated following the International Conference for Harmonization (ICH) Q2 (R1) guidelines. The method's accuracy was determined through the percent recovery within the limit of 95 to 105%.

Results: The method demonstrated linearity within the 2-10 µg/ml range, exhibiting a regression coefficient of 0.997. The precision of the method was indicated by the percentage RSD, which was recorded to be less than 2%. Limit of detection (LOD), and limit of quantification (LOQ) were found to be 1.6 µg/ml and 4.8 µg/ml, respectively. The proposed approach has been proved to be robust because the response did not significantly change due to a change in the rate of flow, along with the composition of the mobile phase.

Conclusion: The results of the study demonstrated that the developed method has passed all the validation test parameters and can be applied for the estimation of RES in bulk dosage form, commercial tablet, and developed multiwalled carbon nanotube (MWCNTs)-based formulations.

References

1. Singh G, Pai RS. A rapid reversed-phase HPLC method for analysis of trans resveratrol in PLGA nanoparticulate formulation. ISRN Chromatogr. 2014 Feb;2014:1-6. doi: 10.1155/2014/248635.

2. Zhu XD, Lei XP, Dong WB. Resveratrol as a potential therapeutic drug for respiratory system diseases. Drug Des Dev Ther. 2017 Dec;11:3591-8. doi: 10.2147/DDDT.S148868, PMID 29290681.

3. Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi Rad M. Resveratrol: a double-edged sword in health benefits. Biomedicines. 2018 Sep;6(3):91. doi: 10.3390/biomedicines6030091, PMID 30205595.

4. Liu X, Pei J, Li J, Zhu H, Zheng X, Zhang X. Recent advances in resveratrol derivatives: structural modifications and biological activities. Molecules. 2025 Feb;30(4):958. doi: 10.3390/molecules30040958, PMID 40005268.

5. Kumar B. Resveratrol inhibits expression of cancer-specific pentose phosphate pathway enzyme TKTL1. Asian J Pharm Clin Res. 2018 Jun;11(6):332. doi: 10.22159/ajpcr.2018.v11i6.25021.

6. Abu Amero KK, Kondkar AA, Chalam KV. Resveratrol and ophthalmic diseases. Nutrients. 2016 Apr;8(4):200. doi: 10.3390/nu8040200, PMID 27058553.

7. Seukep JA, Sandjo LP, Ngadjui BT, Kuete V. Antibacterial and antibiotic resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against gram negative multi-drug resistant phenotypes. BMC Complement Altern Med. 2016 Jul;16(1):193. doi: 10.1186/s12906-016-1173-2, PMID 27386848.

8. Meyer C, Brockmueller A, Ruiz De Porras VR, Shakibaei M. Microbiota and resveratrol: how are they linked to osteoporosis? Cells. 2024 Jul;13(13):1145. doi: 10.3390/cells13131145, PMID 38994996.

9. Oliveira AR, Domingues FC, Ferreira S. The influence of resveratrol adaptation on resistance to antibiotics benzalkonium chloride heat and acid stresses of Staphylococcus aureus and Listeria monocytogenes. Food Control. 2017;73:1420-5. doi: 10.1016/j.foodcont.2016.11.011.

10. Kataria R, Khatkar A. Resveratrol in various pockets: a review. Curr Top Med Chem. 2019 Mar;19(2):116-22. doi: 10.2174/1568026619666190301173958, PMID 30834833.

11. Trombino S, Cassano R, Di Gioia ML, Aiello F. Emerging trends in green extraction techniques chemical modifications and drug delivery systems for resveratrol. Antioxidants (Basel). 2025 May;14(6):654. doi: 10.3390/antiox14060654, PMID 40563289.

12. Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J. Anti-inflammatory action and mechanisms of resveratrol. Molecules. 2021 Jan;26(1):229. doi: 10.3390/molecules26010229, PMID 33466247.

13. Huo Y, Yang D, Lai K, Tu J, Zhu Y, Ding W. Antioxidant effects of resveratrol in intervertebral disk. J Invest Surg. 2022 Oct;35(5):1135-44. doi: 10.1080/08941939.2021.1988771, PMID 34670455.

14. Wenzel E, Somoza V. Metabolism and bioavailability of trans resveratrol. Mol Nutr Food Res. 2005 Mar;49(5):472-81. doi: 10.1002/mnfr.200500010, PMID 15779070.

15. Jarosova V, Vesely O, Doskocil I, Tomisova K, Marsik P, Jaimes JD. Metabolism of cis and trans resveratrol and dihydroresveratrol in an intestinal epithelial model. Nutrients. 2020 Feb;12(3):595. doi: 10.3390/nu12030595, PMID 32106482.

16. Gambini J, Ingles M, Olaso G, Lopez Grueso R, Bonet Costa V, Gimeno Mallench L. Properties of resveratrol: in vitro and in vivo studies about metabolism bioavailability and biological effects in animal models and humans. Oxid Med Cell Longev. 2015 Jan;2015:837042. doi: 10.1155/2015/837042, PMID 26221416.

17. Annaji M, Poudel I, Boddu SH, Arnold RD, Tiwari AK, Babu RJ. Resveratrol loaded nanomedicines for cancer applications. Cancer Rep (Hoboken). 2021 Mar;4(3):e1353. doi: 10.1002/cnr2.1353, PMID 33655717.

18. Perrone D, Fuggetta MP, Ardito F, Cottarelli A, De Filippis A, Ravagnan G. Resveratrol (3,5,4′-trihydroxystilbene) and its properties in oral diseases. Exp Ther Med. 2017 May;14(1):3-9. doi: 10.3892/etm.2017.4472, PMID 28672886.

19. Wu Z, Wang N, Ye Z, Xu H, Chan G, Ouyang D. Formulation BCS: a machine learning platform based on diverse molecular representations for biopharmaceutical classification system (BCS) class prediction. Mol Pharm. 2025;22(1):330-42. doi: 10.1021/acs.molpharmaceut.4c00946, PMID 39647169.

20. Truzzi F, Tibaldi C, Zhang Y, Dinelli G, D Amen E. An overview on dietary polyphenols and their biopharmaceutical classification system (BCS). Int J Mol Sci. 2021 May;22(11):5514. doi: 10.3390/ijms22115514, PMID 34073709.

21. Ali HE, Radwan RR. Synthesis characterization and evaluation of resveratrol loaded functionalized carbon nanotubes as a novel delivery system in radiation enteropathy. Eur J Pharm Sci. 2021 Sep;167:106002. doi: 10.1016/j.ejps.2021.106002, PMID 34517108.

22. Srivastava N, Mishra Y, Mishra V, Ranjan A, Tambuwala MM. Carbon nanotubes in breast cancer treatment: an insight into properties functionalization and toxicity. Anticancer Agents Med Chem. 2023 May;23(14):1606-17. doi: 10.2174/1871520623666230510094850, PMID 37165493.

23. Srivastava N, Mishra V, Mishra Y, Ranjan A, Aljabali AA, El Tanani M. Development and evaluation of a protease inhibitor antiretroviral drug loaded carbon nanotube delivery system for enhanced efficacy in HIV treatment. Int J Pharm. 2024;650:123678. doi: 10.1016/j.ijpharm.2023.123678, PMID 38065344.

24. Witkowska M, Florek E, Mrowczynski R. Assessment of pristine carbon nanotubes toxicity in rodent models. Int J Mol Sci. 2022 Dec;23(23):15343. doi: 10.3390/ijms232315343, PMID 36499665.

25. Saleemi MA, Hosseini Fouladi MH, Yong PV, Chinna K, Palanisamy NK, Wong EH. Toxicity of carbon nanotubes: molecular mechanisms, signaling cascades and remedies in biomedical applications. Chem Res Toxicol. 2021;34(1):24-46. doi: 10.1021/acs.chemrestox.0c00172, PMID 33319996.

26. Antrim AK, Tseytlin IN, Cooley EG, Fernando PU, Barker ND, Alberts EM. Acute toxicity of carbon nanotubes carbon nanodots and cell penetrating peptides to freshwater cyanobacteria. Toxins. 2025 Apr;17(4):172. doi: 10.3390/toxins17040172, PMID 40278670.

27. Mohammadi E, Zeinali M, Mohammadi Sardoo M, Iranpour M, Behnam B, Mandegary A. The effects of functionalization of carbon nanotubes on toxicological parameters in mice. Hum Exp Toxicol. 2020 Jan;39(9):1147-67. doi: 10.1177/0960327119899988, PMID 31957491.

28. Ursini CL, Cavallo D, Fresegna AM, Ciervo A, Maiello R, Buresti G. Differences in cytotoxic genotoxic and inflammatory response of bronchial and alveolar human lung epithelial cells to pristine and COOH-functionalized multiwalled carbon nanotubes. Biomed Res Int. 2014 Jan;2014:359506. doi: 10.1155/2014/359506, PMID 25147797.

29. Xu S, Luo H, Chen H, Guo J, Yu B, Zhang H. Optimization of extraction of total trans resveratrol from peanut seeds and its determination by HPLC. J Sep Sci. 2020 Jan;43(6):1024-31. doi: 10.1002/jssc.201900915, PMID 31916409.

30. Santos AC, Veiga FJ, Sequeira JA, Fortuna A, Falcao A, Pereira I. First time oral administration of resveratrol loaded layer by layer nanoparticles to rats a pharmacokinetics study. Analyst. 2019 Jan;144(6):2062-79. doi: 10.1039/c8an01998c, PMID 30724915.

31. Katsagonis A, Atta Politou J, Koupparis MA. HPLC method with UV detection for the determination of trans resveratrol in Plasma. J Liq Chromatogr Relat Technol. 2005;28(9):1393-405. doi: 10.1081/JLC-200054884.

32. Ramesh D, Habibuddin M. Application of validated RP-HPLC method for simultaneous determination of metaxalone and diclofenac potassium in plasma. Int J Curr Pharm Sci. 2024 Jul;16(4):89-94. doi: 10.22159/ijcpr.2024v16i4.5039.

33. Juan ME, Maijo M, Planas JM. Quantification of trans resveratrol and its metabolites in rat plasma and tissues by HPLC. J Pharm Biomed Anal. 2010;51(2):391-8. doi: 10.1016/j.jpba.2009.03.026, PMID 19406597.

34. Sunsong R, Du T, Etim I, Zhang Y, Liang D, Gao S. Development of a novel UPLC-MS/MS method for the simultaneously quantification of polydatin and resveratrol in plasma: application to a pharmacokinetic study in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Oct;1185:123000. doi: 10.1016/j.jchromb.2021.123000, PMID 34710805.

35. Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA. Quantitation of trans resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;848(2):182-7. doi: 10.1016/j.jchromb.2006.10.017, PMID 17097357.

36. Moon H, Park J, Hwang J, Chung H. Magnetic solid phase extraction of drugs and pesticides from human plasma using COOH-mMWCNTs. J Anal Toxicol. 2021;44(9):968-75. doi: 10.1093/jat/bkaa029, PMID 32369168.

37. Robinson K, Mock C, Liang D. Pre-formulation studies of resveratrol. Drug Dev Ind Pharm. 2015 Sep;41(9):1464-9. doi: 10.3109/03639045.2014.958753, PMID 25224342.

38. Pentek T, Newenhouse E, O Brien B, Chauhan AS. Development of a topical resveratrol formulation for commercial applications using dendrimer nanotechnology. Molecules. 2017 Jan;22(1):137. doi: 10.3390/molecules22010137, PMID 28098828.

39. Sathishbabu P, Hani U, Shakeela C, Hemanth Vikram PR, Ghazwani M, Osmani RA. A novel RP-HPLC method development and validation for simultaneous quantification of gefitinib and resveratrol in polymeric hybrid lipid nanoparticles and glioma cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Oct;1212:123483. doi: 10.1016/j.jchromb.2022.123483, PMID 36279777.

40. Bhaskararao P, Sarika M, Madhavi CL, Kollipara MG, Prashanthi G. The industrial importance of technology transfer for analytical method development and validation application to vilazodone hydrochloride dosage form. Int J Chem Res. 2024 Oct;8(4):12-7. doi: 10.22159/ijcr.2024v8i4.235.

41. Wu W, Li K, Zhao C, Ran X, Zhang Y, Zhang T. A rapid HPLC–MS/MS method for the simultaneous determination of luteolin resveratrol and their metabolites in rat plasma and its application to pharmacokinetic interaction studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jan;1191:123118. doi: 10.1016/j.jchromb.2022.123118, PMID 35085987.

42. Kurangi B, Jalalpure S, Jagwani S. A validated stability indicating HPLC method for simultaneous estimation of resveratrol and piperine in cubosome and human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May;1122-1123:39-48. doi: 10.1016/j.jchromb.2019.05.017, PMID 31150952.

43. Woldemariam G, Kyad A, Moore S, Qiu J, Semin D, Tan ZJ. Development and validation of a HPLC-UV method for urea and related impurities. PDA J Pharm Sci Technol. 2020;74(1):2-14. doi: 10.5731/pdajpst.2018.009803, PMID 31209168.

44. Tariq M, Thomas S, Singh A, Talegaonkar S. Developed and validated stability indicating HPLC method for the determination of epirubicin in bulk drug marketed injection and polymeric nanoparticles. Braz J Pharm Sci. 2018 Jan;54(4):e17515. doi: 10.1590/s2175-97902018000417515.

45. Srivastava N, Mishra V, Kumar B, Mishra Y, Palanimuthu VR. Bioanalytical method development of nevirapine fosamprenavir calcium and its metabolite amprenavir by RP-HPLC in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Jun 23;1263:124702. doi: 10.1016/j.jchromb.2025.124702, PMID 40570690.

46. Cui L, Liu W, Liu H, Qin Q, Wu S, He S. PH-triggered charge reversal mesoporous silica nanoparticles stabilized by chitosan oligosaccharide/carboxymethyl chitosan hybrids for effective intracellular delivery of doxorubicin. ACS Appl Bio Mater. 2019 Apr;2(5):1907-19. doi: 10.1021/acsabm.8b00830, PMID 35030680.

47. Sahu A, Jain A, Gulbake A. The role of carbon nanotubes in nanobiomedicines. Int J Pharm Pharm Sci. 2017 Jun;9(6):235-51. doi: 10.22159/ijpps.2017v9i6.18522.

48. Zu Y, Zhang Y, Wang W, Zhao X, Han X, Wang K. Preparation and in vitro/in vivo evaluation of resveratrol loaded carboxymethyl chitosan nanoparticles. Drug Deliv. 2016;23(3):971-81. doi: 10.3109/10717544.2014.924167.

49. Ha ES, Park H, Lee SK, Sim WY, Jeong JS, Baek IH. Pure trans resveratrol nanoparticles prepared by a supercritical antisolvent process using alcohol and dichloromethane mixtures: effect of particle size on dissolution and bioavailability in rats. Antioxidants (Basel). 2020 Apr;9(4):342. doi: 10.3390/antiox9040342, PMID 32331478.

50. Yuan X, Zhou Y, Bi J, Li S, Wu H, Zeng M. An antioxidant composite film based on loquat seed starch incorporating resveratrol loaded core shell nanoparticles. Int J Biol Macromol. 2025 Feb;306(3):141493. doi: 10.1016/j.ijbiomac.2025.141493, PMID 40023425.

51. Tomic N, Matic T, Filipovic N, Mitic Culafic DM, Boccacccini AR, Stevanovic MM. Synthesis and characterization of innovative resveratrol nanobelt like particles and assessment of their bioactivity antioxidative and antibacterial properties. J Biomater Appl. 2023 Jun;38(1):122-33. doi: 10.1177/08853282231183109, PMID 37303075.

52. Long Huang KL, Hu L, Liu SQ. Preparation and characterization of disulfide functionalized multi-walled carbon nanotubes for biomedical applications. Int J Chem. 2010 Jul;2(2):144-8. doi: 10.5539/ijc.v2n2p144.